A defective mutant of Salmonella enterica Serovar Gallinarum in cobalamin biosynthesis is avirulent in chickens

Mutante de Salmonella enterica serovar Gallinarum duplo defectivo na biossíntese de cobalamina é avirulento para aves

Abstracts

Salmonella enterica serovar Gallinarum (SG) é o agente do tifo aviário, doença severa que provoca mortalidade em até 80% do plantel de aves. SG encontra-se entre os poucos sorotipos de Salmonella que são agentes etiológicos de enfermidade específica, à semelhança de Salmonella Typhi em seres humanos podendo, portanto, servir de modelo experimental para outras salmoneloses hospedeiro especíifcas. Além dos mecanismos de virulência, a bactéria utiliza mecanismos de sobrevivência para permanecer no hospedeiro. A ativação desses mecanismos pode ou não estar associada à ativação dos mecanismos de virulência. Entre os mecanismos fisiológicos, está a produção de vitamina B12 que Salmonella spp. realiza em ambientes anaeróbicos, como quando encontra-se intracelularmente no organismo hospedeiro. Neste estudo, analisou-se a infecção de aves por cepas de SG, que tiveram genes alterados que participam da biossíntese de vitamina B12. Foram produzidos mutantes de SG contendo os genes cbiA e cobS alterados e um terceiro, contendo ambos os genes alterados. A sobrevivência e a ação patogênica de SG não foi modificada pela alteração simples de um dos genes, mas tornou a cepa de SG completamente atenuada quando os dois foram modificados. A mortalidade provocada pela cepa selvagem de SG foi de 64,52%, enquanto que não observou-se mortalidade alguma no grupo de aves infectadas com SGNal r"cobs"cbiA. Estudos futuros deverão ser realizados para elucidar este processo fisiológico bacteriano e para avaliar a utilização desta cepa de SG como cepa vacinal.

Salmonella Gallinarum; cobalamina; mutantes de Salmonella; atenuação de genes

VETERINARY MICROBIOLOGY

A defective mutant of Salmonella enterica Serovar Gallinarum in cobalamin biosynthesis is avirulent in chickens

Mutante de Salmonella enterica serovar Gallinarum duplo defectivo na biossíntese de cobalamina é avirulento para aves

Jacqueline Boldrin de Paiva^I; Rafael Antonio Casarin Penha Filho^I; Yuli Melisa Sierra Arguello^I; Ângelo Berchieri JuniorI, ^*; Manuel Victor Franco Lemos^I; Paul A. Barrow^II

^IFaculdade de Ciências Agrárias e Veterinárias, Universidade Estadual Paulista, Jaboticabal, SP, Brasil

^IISchool of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, Loughborough LE12 5RD, UK

ABSTRACT

Salmonella enterica serovar Gallinarum (SG) is a fowl typhoid agent in chickens and is a severe disease with worldwide economic impact as its mortality may reach up to 80%. It is one of a small group of serovars that typically produces typhoid-like infections in a narrow range of host species and which therefore represents a good model for human typhoid. The survival mechanisms are not considered to be virulent mechanisms but are essential for the life of the bacterium. Mutants of Salmonella Gallinarum containing defective genes, related to cobalamin biosynthesis and which Salmonella spp. has to be produced to survive when it is in an anaerobic environment, were produced in this study. Salmonella Gallinarum is an intracellular parasite. Therefore, this study could provide information about whether vitamin B₁₂ biosynthesis might be essential to its survival in the host. The results showed that the singular deletion in cbiA or cobS genes did not interfere in the life of Salmonella Gallinarum in the host, perhaps because single deletion is not enough to impede vitamin B₁₂ biosynthesis. It was noticed that diluted SG mutants with single deletion produced higher mortality than the wild strain of SG. When double mutation was carried out, the Salmonella Gallinarum mutant was unable to provoke mortality in susceptible chickens. This work showed that B₁₂ biosynthesis is a very important step in the metabolism of Salmonella Gallinarum during the infection of the chickens. Further research on bacterium physiology should be carried out to elucidate the events described in this research and to assess the mutant as a vaccine strain.

Key words:Salmonella Gallinarum , cobalamin biosynthesis, attenuated strain, cbiA and cobS genes

RESUMO

Salmonella enterica serovar Gallinarum (SG) é o agente do tifo aviário, doença severa que provoca mortalidade em até 80% do plantel de aves. SG encontra-se entre os poucos sorotipos de Salmonella que são agentes etiológicos de enfermidade específica, à semelhança de Salmonella Typhi em seres humanos podendo, portanto, servir de modelo experimental para outras salmoneloses hospedeiro especíifcas. Além dos mecanismos de virulência, a bactéria utiliza mecanismos de sobrevivência para permanecer no hospedeiro. A ativação desses mecanismos pode ou não estar associada à ativação dos mecanismos de virulência. Entre os mecanismos fisiológicos, está a produção de vitamina B₁₂ que Salmonella spp. realiza em ambientes anaeróbicos, como quando encontra-se intracelularmente no organismo hospedeiro. Neste estudo, analisou-se a infecção de aves por cepas de SG, que tiveram genes alterados que participam da biossíntese de vitamina B₁₂. Foram produzidos mutantes de SG contendo os genes cbiA e cobS alterados e um terceiro, contendo ambos os genes alterados. A sobrevivência e a ação patogênica de SG não foi modificada pela alteração simples de um dos genes, mas tornou a cepa de SG completamente atenuada quando os dois foram modificados. A mortalidade provocada pela cepa selvagem de SG foi de 64,52%, enquanto que não observou-se mortalidade alguma no grupo de aves infectadas com SGNal^rΔcobsΔcbiA. Estudos futuros deverão ser realizados para elucidar este processo fisiológico bacteriano e para avaliar a utilização desta cepa de SG como cepa vacinal.

Palavras-chaves:Salmonella Gallinarum, cobalamina, mutantes de Salmonella , atenuação de genes, cbiA, cobS.

INTRODUCTION

Salmonella enterica serovar Gallinarum (SG) is the fowl typhoid agent in chickens, a very severe disease with worldwide economic impact and with which mortality may reach up to 80% (5, 9). It is one of a small group of serovars that typically produces typhoid-like infections in a narrow range of host species and which therefore represents a good model for human typhoid. The disease is most severe where environmental conditions and management systems do not allow hygienic control measures to be introduced (36). Although a live vaccine (SG9R strain) is commercially available and has been used extensively, it harbor undefined attenuations and retains a degree of virulence (18, 19, 28, 48). Despite of additional strains having been described of having more defined mutations (5, 7, 8, 22, 56) none of these combine the high level of protection of the 9R strain with its ability to stimulate a specific circulating antibody (55). There thus remains considerable scope for further exploration of the virulence basis of this pathogen.

To survive intracellularly, SG uses anaerobic respiration to obtain its energy (20). As part of its ability to adapt to different growth conditions, SG may alter the composition of its respiratory system (23, 39). Different components can be substituted in the membrane in place of or in addition to other components as they are needed and can become fully functional parts of the entire system (32, 33). There are three types of respiratory components. (i) Substrate-specific dehydrogenases, which carry out the oxidation of organic substrates and feed electrons into the mobile quinone pool; (ii) quinones, which deliver reducing equivalents to the terminal oxidoreductases; and (iii) terminal oxidoreductases, which prevent the terminal electron acceptors from being used (17). The amount of each component is strictly regulated to optimize the respiratory chain according to the substrates present and the physiological needs of the cell (34) Bacteria can use substrates other than NADH, such as succinate, pyruvate, or lactate as primary electron donors and a number of alternative electron acceptors, such as dimethyl sulfoxide, fumarate, and nitrate, in addition to oxygen (17). Despite of the extensive understanding of bacterial electron transport and proton translocation, little is known about the relative contribution of the relevant protontranslocation enzymes to the growth and survival of pathogens in the host in either the gut or the intracellular environment.

Virtually all Salmonella isolates synthetize vitamin B₁₂ (cobalamin or CBL) de novo under anaerobic conditions alone. The synthesis can take place under aerobiosis only if the bacterium is provided by precursor substances such as cobinamide. (13, 24, 27). The ability to synthesize and import B12 requires more than 35 known genes (42). This means 1% of the microorganism genome (46), in addition to an extra 1% related to metabolic activity involving cobalamin. This large genetic investment in vitamin B₁₂ suggests that a B_12- dependent metabolism is important to natural populations of Salmonella (53). Mutations that eliminate B₁₂ synthesis from otherwise wildtype strains cause no growth defect under the standard aerobic or anaerobic lab conditions used so far. The CBL biosynthetic operon of Salmonella Typhimurium is made up of 20 putative genes. These genes are organized in a single operon and can be separated into two groups: (i) genes involved in corrin ring synthesis, designated cbi (the operon contains 17 cbi genes, cbiA being the first) and (ii) genes involved in nucleotide loop assembly, designated cob (the operon contains three genes: cobU, cobS and cobT) (37).

The biologically active forms of vitamin B₁₂ are required in methylation, reduction and intramolecular rearrangements reactions (13, 47, 54). A low redox potential generated during the anaerobic growth, increases expression of the cob operon 4 to 100 fold (2, 3, 14).

Cobalamin is used as a cofactor in four known reactions in STM: (i) it is required by one methyltransferase (metH gene product) that catalyzes the last step in the methionine B12 dependent biosynthesis (43); (ii) it is required for the degradation of ethanolamine to acetaldehyde and ammonia providing both a carbon and a nitrogen source (12, 42); (iii) B₁₂ is involved in the formation of the nonessential hypermodified Q base found in position 34 in the anticodon of RNAt ^{Asp,Asn,His,Tyr} (16, 35).

The main use of B₁₂ in Salmonella appears to be a cofactor for propanediol dehydratase, the first enzyme in propanediol degradation. This conclusion is based on the fact that the cob operon, is induced by propanediol and is co-regulated with the pdu operon, which are encoding genes for propanediol degradation (11, 41). This control pattern suggests that perhaps propanediol could be used as a useful carbon and energy source which is frequently valuable and available under anaerobic conditions, because it is made as a by-product during degradation of common plant sugars (29, 53). Mutants blocked in B₁₂ synthesis show harmed anaerobic growth in carbon poor sources (38). The propanediol supports anaerobic growth when tetrathionate (not another acceptor) is used as an alternative electron acceptor (38, 53).

CbiA (Cobyrinic acid a,cdiamide sintetase) is the first glutamina aminotransferase in the anaerobic pathway of vitamin B₁₂ and catalyzes reactions in many sites of the substrate. CbiA is an indirect response by cob operon repression (40). CobS enzyme (Adenosylcobalamin5'-P synthase) is bound to the cellular membrane and catalyzes the second to last step of the Ado-CBL production (30). The cobalamin biosynthesis is completely dependent on this enzyme (1, 31). The deletion of cobS and cbiA genes prevent any form of cobalamin production (Adenosyl-, Cyano-, Methyl-, Hidroxi-B₁₂) under anaerobic conditions by Salmonella mutants (40). However, the exact relation is unknown.

Studies to understand the pathogenicity of Salmonella look for virulence genes. Although, the survival mechanisms are not considered to be virulent mechanisms, they are essential for the life of the bacterium. In this study, mutants of SG containing defective genes related to cobalamin biosynthesis were produced. Since SG is an intracellular parasite, the study might provide information about whether vitamin B₁₂ biosynthesis could be essential to its survival in the host.

MATERIAL AND METHODS

Bacterial strain and culture media:Salmonella enterica serovar Gallinarum strain 9 produces typical systemic fowl typhoid with high mortality (36, 49). For ease of enumeration, spontaneous nalidixic acidresistant (25µg/mL) mutant derivates of this strain were used. The mutants were constructed from Salmonella Typhimurium F98 Nal^r strain. The DNA homology was such as to permit using the same inactivated serovar Typhimurium sequences in serovar Gallinarum. The construction of the mutants, conjugation and transduction followed Sambrook & Russel (44) and Turner et al. (51).

Broth cultures consisted of 10mL volumes of LB broth (Invitrogen Nº 12780-052) incubated for 24h/37ºC in a shaking incubator (100 rpm). The broth culture contained approximately 1x10⁸ (S. Gallinarum) and 1.2 x10⁹ (S. Typhimurium) CFU/mL.

Mutant construction: Mutants were constructed in cobalamin biosynthesis deficiency. In brief, four primers were designed for each gene to be mutated, so that two fragments close to the 5' and 3' ends of the gene could be amplified leaving a central deletion in the amplified gene and incorporating KpnI (Gibco 15232) or BamHI (Gibco 15201) sites facilitating the insertion of a kanamycin (cbiA gene) or spectinomycin (cobS gene) cassette. Initial cloning was carried out in pGEM T Easy vector (Promega L2001) and then in the pJCB12 suicide vector in E.coli S.17.1λ pir, which was used for conjugation into SG 9 Nal^r. Mutants were selected based on their resistance to kanamycin or on streptomycin and ampicillin sensitivity and were checked for Salmonella O-antigens by slide agglutination with antisera and for smoothness by absence of agglutination with acriflavin (0.001%). The integrity of the constructs was checked by PCR using the same primers (Figure 1).

Primers designed:

cobS:

Primer 1: gagatctagaacgaatctgctgtttgcgct

Primer 2:cagcagggtacctagcggaataccacaccag

Primer 3: ccgctaggtaccctgctgaccggtggttttca

Primer 4: tctagaacagacccagcagaaagatc

cbiA:

Primer 1: catctagaaaggcatcacgcatttattc

Primer 2: ccgtaaggtaccaatggcatttttgaggagct

Primer 3: gccattggtaccatacggtgatgttaaaacat

Primer 4: tgtctagacagccagtgctgcaacattt

Transduction:Mutants of SG with double deletions were obtained by transduction using bacteriophage P22 following standard protocols (4, 44). Transductants were plated on LB agar (Invitrogen Nº 22700-025) containing spectinomycin or kanamycin and after incubation at 37C/24h were again checked by PCR.

Virulence assays

Experiment 1. Assessment of mortality: Virulence was assessed by oral inoculation of groups of five-day-old brown commercial layers with 0.5 mL of either an undiluted culture containing 10⁸ CFU/mL or diluted at 10^-2 to contain 10⁶ CFU/mL of mutant and wild cultures of Salmonella Gallinarum. This variety of commercial brown chickens was chosen because it is susceptible to clinical fowl typhoid (9, 15). Mortality was recorded over a period of 28 days. Data were assessed by Quisquare test (p<0.05) (21).

Experiment 2. Assessment of systemic infection: The systemic infection was assessed by oral inoculation of groups of five-day-old brown commercial layers with 0.5 mL of the mutant or wild culture containing 10⁸ CFU/mL. The bacteriological analysis was carried out as described by Barrow & Lovell (6) with some modification. At 2, 5, 7, 14, 21 and 28 days postinoculation (dpi), samples from the spleen and liver were collected and diluted (1:10) in phosphatebuffered saline, pH 7.4 (PBS). The organ samples were macerated in a pestle and mortar. The viable count of SGNal^r ΔcobSΔcbiA and SGNal^r in the samples were estimated by plating aliquots of decimal dilutions on BGA Nal/Nov incubated overnight at 37ºC. The first dilution of the sample was added to an equal volume of doubleconcentrated SN. This was incubated at 37ºC overnight and plated on BGANal/Nov agar plate when there was no growth from the viable count. Data of viable counts were transformed logarithmically (log₁₀) and subjected to analysis of variance. Media were compared statistically by Tukey test (p < 0.05).

RESULTS

In experiment 1, the mortality caused by SG ΔcobS or/and ΔcbiA genes was assessed (Table 1). In groups where the birds were challenged with neat culture of the strains containing single mutation, the mortality was similar to group of birds receiving the wild strain of SGNal^r, and there was no mortality in birds inoculated with SG Nal^rΔcobSΔcbiA (p<0.05). At lower dose, however, SG ΔcobS and SGΔcbiA provoked mortality higher than SGNal^r (p<0.05).

Figure 2 shows the results on the presence of SG Nal^r ΔcobSΔcbiA in the liver and spleen of birds over a period of 28 days postinfection (dpi) in comparison with the infection of birds by the wild SG strain. Five birds in each group were inspected at 2, 5, 7, 14, 21 and 28 dpi. There was always a smaller quantity of the SG Nal^r ΔcobSΔcbiA strain in the liver and spleen than there was of the SGNal^r strain (p<0.05). Mortality by SGNal^r strain started around seven dpi and all of remaining birds died before 14dpi whereas no mortality was seen in group of birds infected with SG Nal^r ΔcobSΔcbiA.

DISCUSSION AND CONCLUSION

Fowl typhoid is a systemic disease in chickens caused by Salmonella Gallinarum, an intracellular anaerobic facultative parasite. It is a very severe disease and during its course, the bacterium persists intracellularly. The virulence factors are responsible for the development and evolution of the illness (52). The bacterium also uses other resources to survive intracellularly. To breathe anaerobically, Salmonella produces enzymatic complexes according to the available substrate in the host cell. Sometimes, under certain circumstances, enzymatic complexes could inhibit each other's action.

In the present work, mutants of SG containing defective genes related to cobalamin biosynthesis were prepared. These mutants were inoculated orally in 5-day-old chickens susceptible to clinical fowl typhoid. For SGNal^r ΔcobS and SGNal^rΔcbiA, the lower dose provoked higher mortality in comparison to the wild strain (p<0.05), while there was no mortality in groups of birds inoculated with the strain with double mutation (SGNal^r ΔcbiAΔcobS). These results were similar to findings of Sampson & Gotschlich (45) that discussed the possibility of the Salmonella Typhimurium cob^- mutant strain being more virulent than the wild strain in mice. Sampson & Gotschlich (45) suggested that the inability to produce vitamin B₁₂ might be the factor, which is responsible for increasing its virulence. However, the strain of SG containing double defective genes, cbiA and cobS, was completely attenuated, provoking no mortality. There is also the fact that the bird's life span is shorter than that of the wild strain of SG. There is no explanation why the single mutation in cbiA and cobS genes might increase the virulence and why the double mutant loses it. The explanation given by Sampson & Gotschlich (45) cannot be accepted since works carried out later demonstrated that the wild STM strain used for comparison with cobS mutant was naturally attenuated (10).

According to Jeter et al. (24), Salmonella Typhimurium may be unable to synthesize cobalamin for three reasons: (i) - the phenotipically defective strain in branch I (cob) synthesizes cobalamin only when cobinamide is supplied; (ii) - the defective strain in branch II (cob) synthesizes cobalamin only when dimethylbenzimidazole (DMB) is supplied; and (iii) - the defective strain in branch III (cob) fails to make cobalamin even when provided with both precursors (cobinamide or DMB). Therefore, the SGNal^r ΔcobS strain which has altered branch III, and SGNal^r ΔcbiA which has altered branch I should be incapable of synthesizing cobalamin (vitamin B₁₂). However, in this study, single mutation exacerbated the virulence of SG, and only when the bacterium was defective in two genes did the strain become attenuated. Hence, it is not possible to understand the role that cobalamin plays in the virulence of the bacterium. Perhaps, when the mutant has a single alteration, additional pathway takes place in the bacterium while the double alteration cannot be overcome. According to Roth et al. (43), the cbiA gene is located in part I of the cob operon and it is the first place to start the transcription for the biosynthesis of cobalamin in S. Typhimurium, which codifies an amidase that acts later in the biosynthesis via. Thus, the double mutant has defective genes that act in branch I (cbiA) and branch III (cobS).

It is possible that vitamin B12 within the bacterium is capable of regulating a gene or a group of genes which directly or indirectly control any virulence factor. Another possibility is that somehow it was sensed by the host. This detection might conceivably cause an altered response by the host resulting in less virulent infection.

Huang et al. (23) showed that cob operon expression is induced during the infection of pigs by STM, where according to them possible environmental signals exist specifically in the lymphoid tissues that induce the cob operon, either as a life requirement in this tissue itself or as a prelude to passage into the intestinal tract. Previous work has shown that the invasion of epithelial cells by Salmonella is co-regulated with propenodiol and ethanolamine catabolism including cob expression (25, 26). It is possible that environmental cues encountered by Salmonella are regulated by both metabolic and virulent functions in the host.

The results obtained showed that the singular deletion in cbiA or cobS genes did not interfere in the life of SG in the host, perhaps because single deletion is not enough to impede Paiva, J.B. et al. vitamin B₁₂ biosynthesis. It was noticed that diluted SG mutants with single deletion produced higher mortality than the wild strain of SG did. When double mutation was carried out, the mutant of SG was unable to provoke mortality in susceptible chickens. Further work towards bacterium physiology should be carried out to elucidate the events described in this research.

ACKNOWLEDGEMENT

The authors were thankful to FAPESP and CNPq by financial supports.

Submitted: January 14, 2009;

Returned to authors for corrections: February 11, 2009;

Approved: May 03, 2009.

• 1. Anderson, P.J.; Lango, J.; Carkeet, C.; Britten, A.; Kräutler, B.; Hammock, B.D.; Roth, J.R. (2008). One pathway can incorporate either adenine or dimethylbenzimidazole as an alphaaxial ligand of B12 cofactors in Salmonella enterica. J. Bacteriol 190 (4), 1160-1171.
• 2. Andersson, D.I.; Roth J.R. (1989a). Mutations affecting regulation of cobinamide biosynthesis in Salmonella typhimurium. J. Bacteriol 171 (12), 6726-6733.
• 3. Andersson, D.I.; Roth, J.R. (1989b). Redox regulation of the genes for cobinamide biosynthesis in Salmonella typhimurium. J. Bacteriol 171 (12), 6734-6739.
• 4. Barrow, P.A.; Hassan, J.O.; Berchieri Jr, A. (1990). Reduction in faecal excretion by chickens of Salmonella typhimurium by immunization with avirulent mutants of S. typhimurium. Epidemiol. Infect 104 (3), 413-426.
• 5. Barrow, P.A. (1990). Immunity to experimental fowl typhoid in chickens induced by a virulence plasmid-cured derivative of Salmonella gallinarum. Infect. Immun 58 (7), 2283-2288.
• 6. Barrow, P.A.; Lovell, M.A. (1991). Experimental infection of egg-laying hens with Salmonella enteritidis phage type 4. Avian Pathol 20 (2), 335-348.
• 7. Barrow, P.A.; Lovell, M.A.; Old, D.C. (1992). In vitro and in-vivo characteristics of TnphoA mutant strains of Salmonella serotype Gallinarum not invasive for tissue culture cells. J. Med. Microbiol 36, 389-397.
• 8. Barrow, P.A.; Lovell, M.A.; Stocker, B.A.D. (2000). Protection against experimental fowl typhoid by parenteral admininstration of live SL5928, an aroA-serC (aromatic dependent) mutant of a wild-type Salmonella Gallinarum strain made lysogenic for P22sie. Avian Pathol 29 (5), 423-431.
• 9. Berchieri Jr, A.; Oliveira, G.H.; Pinheiro, L.A.P.; Barrow, P.A. (2000). Experimental Salmonella Gallinarum infection in light laying hens lines. Braz. J. Microbiol 31 (1), 50-52.
• 10. Björkman, J.; Rhen, M.; Anderson, D.I. (1996). Salmonella Typhimurium cob mutants are not hypervirulent. FEMS Microbiol. Lett 139 (2), 121-126.
• 11. Bobik, T.A.; Ailion, M.; Roth, J.R. (1992). A single regulatory gene integrates control of vitamin B12 synthesis and propanediol degradation. J. Bacteriol 174 (7), 2253-2266.
• 12. Chang, G.W.; Chang, J.T. (1975). Evidence for the B12-dependent enzyme ethanolamine deaminase in Salmonella. Nature 254, 150-151.
• 13. Escalante-Semerena, J.C. (2007). Conversion of cobinamide into adenosylcobamide in bacteria and archaea. J. Bacteriol 189 (13), 455-460.
• 14. Escalante-Semerena, J.C.; Roth, J.R. (1987). Regulation of cobalamin biosynthetic operons in Salmonella typhimurium. J. Bacteriol 169 (5), 2251-2258.
• 15. Freitas, O. C.; Arroyave, W.; Alessi, A. C.; Fagliari, J.J.; Berchieri Jr, A. (2007). Infection of commercial laying hens with Salmonella Gallinarum: Clinical, anatomopathological and haematological studies. Braz. J. Poultry Sci 9 (2), 133-141.
• 16. Frey, B.; Mc-Closkev, J.; Kersten, J.; Wkersten, H. (1988). New function of vitamin B12: cobamide-dependent reduction of epoxyqueuosine to queuosine in tRNAs of Escherichia coli and Salmonella typhimurium. J. Bacteriol 170 (5), 20782082.
• 17. Gennis, R.B.; Stwart, V. (1996). Respiration. In: Neidhardt, F.C.; Curtiss III R.; Ingraham, J.L.; Lin, E.C.C.; Low K.B.; Maganasik, B.; Reznikoff, W.S.; Riley, M.; Schaechter, M.; Umbarger, H.E. (eds). Escherichia coli and Salmonella : Cellular and molecular biology American Society for Microbiology, Washington D.C., USA, p. 217 - 261.
• 18. Gordon, W.A.M.; Luke, D. (1959). A note on the use of the 9R fowl typhoid vaccine in poultry breeding flocks. Vet. Rec 71 (44), 926-927.
• 19. Gordon, R.F.; Garside, J.S.; Tucker, J.F. (1959). A note on the use of living attenuated vaccines in the control of fowl typhoid. Vet. Rec 71 (44), 300-305.
• 20. Gottschalk, G. (1986). Bacterial Metabolism. In: Springer-Veralg, New York, 359p.
• 21. Greenwood, P.S.; Nikulin, M.S. (1996). In: WILEY, J. (Ed). A Guide to Chi-Squared Testing. New York, p. 280,
• 22. Griffin, H.G.; Barrow, P.A. (1993). Construction of an aroA mutant of Salmonella serotype Gallinarum: its effectiveness in immunization against experimental fowl typhoid. Vaccine 11 (4), 457-462.
• 23. Huang, Y.; Leming, C.L.; Suyemoto, M.; Altier, C. (2007). Genomewide screen of Salmonella genes expressed during infection in pigs, using in vivo expression technology. Appl. Environ. Microbiol 73 (23), 7522-7530.
• 24. Jeter, R.; Oliveira, B.M.; Roth, J.R. (1984). Salmonella typhimurium synthesizes cobalamin (vitamin B₁₂) de novo under anaerobic growth conditions. J. Bacteriol 159 (1), 206-216.
• 25. Lawhon, S.D.; Frye, J.G.; Suyemoto, M.; Porwollik, S.; Mcclelland, M.; Altier, C. (2003). Global regulation by CsrA in Salmonella typhimurium. Mol. Microbiol 48 (6), 1633-1645.
• 26. Lawhon, S.D.; Maurer, R.; Suyemoto, M.; Altier, C. (2002). Intestinal short-chain fatty acids alter Salmonella Typhimurium invasion gene expression and virulence through BarA/SirA. Mol. Microbiol 46 (5), 1451-1464
• 27. Lawrence, J.G.; Roth, J.R. (1995). The cobalamin (coenzyme B12) biosynthetic genes of Escherichia coli, J. Bacteriol 177 (22), 6371-6380.
• 28. Lee, Y.J.; Mo, I.P.; Kang, M.S. (2005). Safety and efficacy of Salmonella gallinarum 9R vaccine in young laying chickens. Avian Pathol 34 (4), 362-366.
• 29. Lin, E.C.C. (1987). Dissimilatory pathways for sugars, polyols, and carboxy-lates, In: F.D. Neidhardt, J.L. Ingraham, K.B. Low, B. Magasanik, M. Schaechter & H.E. Umbarger. Escherichia coli and Salmonella Typhimurium: cellular and molecular biology American Society for Microbiology, Washington, USA, p. 244-284.
• 30. Maggio-Hall, L.A., Claas, K.R.; EscalanteSemerena, J.C. (2004). The last step in coenzyme B₁₂ synthesis is localized to the cell membrane in bacteria and archaea. Microbiology 150 (5), 13851395.
• 31. Maggio-Hall, L.A.; EscalanteSemerena, J.C. (1999). In vitro synthesis of the nucleotide loop of adenosylcobalamin by Salmonella Typhimurium enzymes. Proc. Nat. Acad. Sci 96 (21), 11798-11803.
• 32. Mahan, M.J.; Slauch, J.M.; Mekalanos, J.J. (1993). Selection of bacterial virulence genes that are specifically induced in host tissues. Sci, 259, 686688.
• 33. Mekalanos, J.J. (1992) Enviromental signals controlling expression of virulence determinats in bacteria. J. Bacteriol 174 (1), 17.
• 34. Moreno-Vivián, C.; Cabello, P.; MartínezLuque, M.; Blasco, R.; Castillo, F. (1999). Prokaryotic nitrate reduction: molecular properties and functional distinction among bacterial nitrate reductases. J. Bacteriol 181 (21), 6573-6584.
• 35. Noguchi, S.; Nishimura, Y.; Hirota, Y.; Nishimura, S. (1982). Isolation and characterization of an Escherichia coli mutant lacking tRNA-guanine transglycosylase. Function and biosynthesis of queuosine in tRNA. J. Biol. Chem 257 (11), 6544-6550.
• 36. Oliveira, G.H.; Fernandes, A.C.; Berchieri Jr, A. (2005). Experimental infection of laying hens with Salmonella enterica serovar Gallinarum. Braz. J. Microbiol 36 (1), 51-56.
• 37. O'Toole, G.A.; Rondon, M.R.; Trzebiatowski, J.R.; Suh, S.; Escalante-Semerena, J.C. (1996). Biosynthesis and utilization of adenosyl-cobalamin (coenzyme B12). In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, H. E. Umbarger. (eds). Escherichia coli and Salmonella: cellular and molecular biology ASM Press, Washington, USA, p.710-720.
• 38. Price-Carter, M.; Tingey, J.; Bobik, T.A.; Roth, JR. (2001). The alternative electron acceptor tetrathionate support B₁₂-dependent anaerobic growth of Salmonella enterica serovar Typhimurium on ethanolamine or 1,2-propanediol. J. Bacteriol 183 (8), 24632475.
• 39. Richardson, D.J. (2000). Bacterial respiration: a flexible process for a changing environment. Microbiology, 146 (2000), 551-571.
• 40. Richter-Dahlfors, A.A.; Ravnum, S. ; Andersson, D.I. (1994). Vitamin B12 repression of the cob operon in Salmonella Typhimurium: translational control of the cbiA gene. Mol. Microbiol 13 (3), 541-553.
• 41. Rondon, M.R.; Escalante-Semerena, J.C. (1992). The poc locus is required for 1,2-propanediol-dependent transcription of the cobalamin biosynthetic (cob) and propanediol utilization (pdu) genes of Salmonella typhimurium. J. Bacteriol 174 (7), 2267-2272.
• 42. Roof, D.M.; Roth, J.R. (1988). Ethanolamine utilization in Salmonellatyphimurium. J. Bacteriol . 170 (9), 38553863.
• 43. Roth, J.R.; Lawrence, J.G.; Rubenfield, M.; Kieffer-Higgins, S.; Church, G.M. (1993). Characterization of cobalamin (vitamin B₁₂) biosynthetic genes of Salmonella typhimurium. J. Bacteriol 175 (11), 3303-3316.
• 44. Sambrook, J.; Russel, D.W. (2001). Molecular cloning. A laboratory manual Cold Spring Harbor Laboratory Press.
• 45. Sampson, B.; Gotschlich, E.C. (1992). Elimination of the vitamin B₁₂ uptake or synthesis pathway does not diminish the virulence of Escherichia coli K1 of Salmonella typhimurium in three model systems. Infect. Immun 60 (9), 3518-3522.
• 46. Schmeiger, H. (1971). A method for detection of phage mutants with altered transducing ability. Mol. Gen. Genet 110 (4), 378-381.
• 47. Schneider, Z.; StroinÄski, A. (1987). Methylcobamide-dependent reactions. In: Z. Schneider, A. StroinÄski. (1987). Comprehensive B12 Chemisty, Biochemistry, Nutrition, Ecology, Medicine De Gruyter, p. 259-266.
• 48. Silva, E.N.; Snoeyenbos, G.H.; Weinack, O.M.; Smyser, C.F. (1981). Studies on the use of the 9R strain of Salmonella Gallinarum as a vaccine in chickens. Avian Dis 25 (1), 38-52.
• 49. Smith, H.W. (1955). Observations on experimental fowl typhoid. J. Comp. Pathol 65 (1), 37-54.
• 50. Smith, H.W.; Tucker, J.F. (1980). The virulence of Salmonella for chickens; their excretion by infected chickens. J. Hyg 84 (3), 479-488.
• 51. Turner, A.K.; ZhangBarber, L.; Wigley, P.; Muhammad, S.; Jones, M.A.; Lovell, M.A.; Hulme, S.; Barrow, P.A. (2003). Contribution of proton-translocating proteins to virulence of Salmonella enterica serovars Typhimurim, Gallinarum and Dublin chickens and mice. Infect. Immun 71 (6), 3392-3401.
• 52. Van Immerseel, F.; Methner, U.; Rychlik, I.; Nagy, B.; Velge, P.; Martin, G.; Foster, N.; Ducatelle, R.; Barrow, P.A. (2005). Vaccination and early protection against non-host-specific Salmonella serotypes in poultry: exploitation of innate immunity and microbial activity. Epidemiol. Infect 133 (6), 959-978.
• 53. Walter, D.; Ailion, M.; Roth, J.R. (1997). Genetic characterization of the pdu operon: use of 1,2-propanediol in Salmonella Typhimurium. J. Bacteriol 179 (4), 1013-1022.
• 54. Warren, M.J.; Raux, E.; Schubert, H.L.; Escalante-Semerena, J.C. (2002). The biosynthesis of adenosylcobalamin (vitamin B12). Nat. Prod. Rep 19 (4), 390-412.
• 55. Zhang-Barber, L.; Turner, A.K.; Barrow, P.A. (1999). Vaccination for control of Salmonella in poultry. Vaccine 17 (20), 2538-2545.
• 56. Zhang-Barber, L.; Turner, A.K.; Dougan, G.; Barrow, P.A. (1998). Protection of chickens against experimental fowl typhoid using a nuoG mutant of Salmonella serotype Gallinarum. Vaccine 16 (9), 899-903.

Publication Dates

• Publication in this collection
  19 Aug 2009
• Date of issue
  Sept 2009

History

• Accepted
  03 May 2009
• Received
  14 Jan 2008
• Reviewed
  11 Feb 2009